DELCF News and Press, Delic Holdings From 03/02/22

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform, recognizes the opportunity within the mental health treatment space and acknowledges the underlying issues affecting people living with these conditions, especially in the United States. Here, over 51.5 m...

Ketamine for the treatment of various mental health conditions, particularly depression , is growing in the United States. However, while the ease of prescription rules is fueling increases in drug offerings, some experts are concerned that this may cause a regulatory crackdown, as the long...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform, is working to make psychedelic-based treatments more accessible and affordable by leveraging its growing chain of clinics in the United States. In 2021, Delic completed the acquisitions of Ketamine Infusi...

A lot has happened over the past weeks in the psychedelics industry . Below, we look at some of the moves companies in this burgeoning sector have made. Last week, Core One Labs Inc. researchers at its Vocan Biotechnologies Inc. subsidiary had received positive results and would begin usi...

The global psychedelics market is estimated to hit $10.75 billion in 2027, with the alternative antidepressant drug market being valued at $15.98 billion in 2023 Already, 65% of individuals dealing with PTSD, depression, and anxiety in the United States believe that psychedelic medicine...

Delic Holdings (CSE: DELC) (OTCQB: DELCF) , the leading psychedelic wellness platform and a company making a mark in the psychedelic wellness scene, recently released results from a survey conducted on its behalf by The Harris Poll. According to a recent article, the survey showed that 65...

Earlier this week, a group of senators in the state of Maryland filed a measure which would establish a fund that could be used to support research into the therapeutic potential of psychedelics. The bill also called for providing free access to psychedelic drugs such as ketamine, MDMA and...

Delic seeks to bring mental health treatment closer to the people through an aggressive expansion plan In a study conducted by The Harris Poll on behalf of the company, it was noted that 65% of Americans dealing with mental health conditions believe that psychedelic medicine should be m...

The psychedelics industry is projected to grow at a compound annual growth rate of 14.5% in the short term, hitting $6.3 billion by 2026 . Psychedelics present an attractive investment opportunity for any investors seeking to diversify their portfolio . However, like most major decisions i...

Delic Lab’s President and Chief Science Officer, Dr. Markus Roggen, will present at the upcoming Emerald Conference on February 28 Delic Labs is a federally licensed research laboratory operating as part of the Delic Holdings ecosystem The laboratory focuses on extraction optim...